Sarah P. Blagden

Performance status score: do patients and their oncologists agree?

Sarah P. Blagden, Susan C. Charman, Linda Sharples et al. · British Journal of Cancer · 2003 · 217 citations · Full text

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

Andrew R. Clamp, Elizabeth C James, Iain A. McNeish et al. · The Lancet · 2019 · 213 citations · Full text

La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

Roni M. Lahr, Bruno D. Fonseca, Gabrielle E. Ciotti et al. · eLife · 2017 · 192 citations · Full text

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

David Olmos, Douglas S. Barker, Rohini Sharma et al. · Clinical Cancer Research · 2011 · 166 citations · Full text

The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer

Thomas G. Hopkins, Manuela Mura, Hiba A. Al-Ashtal et al. · Nucleic Acids Research · 2015 · 157 citations · Full text